Zhongshan Hospital, Xiamen University, Xiamen, Fujian, China.
Medicine (Baltimore). 2022 Mar 18;101(11). doi: 10.1097/MD.0000000000028899.
Acute diarrhea has a serious impact on the health and lives of children. Previous studies have shown that probiotics have positive and reliable efficacy in the treatment of acute diarrhea in children, but the efficacy of different types of probiotics varies. This study will evaluate the clinical efficacy of different kinds of probiotics in the treatment of acute diarrhea in children by means of network meta-analysis.
According to the retrieval strategy, randomized controlled studies on probiotics in the treatment of acute diarrhea in children will be searched from PubMed, Embase, Web of Science, the Cochrane Library, CNQI, Wanfang, VIP, and Chinese biomedical databases. The retrieval time limit will be from the establishment of the database to January 2022. The quality level of the included studies will be assessed using the Cochrane Risk Bias Assessment Tool and the strength of evidence for outcome measures will be assessed using the Grading of Recommendation Assessment, Development, and Evaluation method. All data analysis will be performed by Revman5.3, Gemtc 0.14.3 and Stata 14.0.
This study will evaluate the efficacy of different kinds of probiotics in the treatment of acute diarrhea in children by evaluating diarrhea duration, stool frequency, length of hospital stay, adverse reactions, etc.
This study will provide a reliable evidence-based basis for the selection of probiotics for the treatment of acute diarrhea in children.
Private information from individuals will not be published. This systematic review also does not involve endangering participant rights. Ethical approval will not be required. The results may be published in a peer-reviewed journal or disseminated at relevant conferences.
DOI 10.17605/OSF.IO/MNJAE.
急性腹泻会对儿童的健康和生活造成严重影响。既往研究显示益生菌在儿童急性腹泻治疗中具有积极、可靠的疗效,但不同种类益生菌的疗效存在差异。本研究将采用网状 Meta 分析的方法评价不同种类益生菌治疗儿童急性腹泻的临床疗效。
根据检索策略,从 PubMed、Embase、Web of Science、Cochrane 图书馆、CNKI、万方、维普及中国生物医学文献数据库中检索益生菌治疗儿童急性腹泻的随机对照研究。检索时间限定为各数据库建库至 2022 年 1 月。采用 Cochrane 偏倚风险评估工具评价纳入研究的质量,并采用推荐评估、制定与评价分级方法评估结局指标的证据强度。所有数据分析均采用 Revman5.3、Gemtc 0.14.3 和 Stata 14.0 软件进行。
本研究将通过评价腹泻持续时间、粪便频次、住院时间、不良反应等指标,评价不同种类益生菌治疗儿童急性腹泻的疗效。
本研究将为儿童急性腹泻治疗中益生菌的选择提供可靠的循证依据。
本研究不涉及个体的隐私信息,不会对参与者的权益造成威胁,因此无需伦理审批。研究结果可能会发表在同行评议期刊上,或在相关会议上进行传播。
OSF 注册号:DOI 10.17605/OSF.IO/MNJAE。